Spartalizumab
Spartalizumab (PDR001) is a humanized immunoglobulin G4 monoclonal antibody that selectively binds to PD-1 at low concentrations, exhibiting high activity. It blocks the interaction with PD-L1 and PD-L2, making it suitable for studying undifferentiated thyroid cancer (ATC) .
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
PD-1/PD-L1
CAS Number
1935694-88-4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6339259-01 0.1 mL
PVRL4, ID (PVRL4, LNIR, PRR4, Poliovirus receptor-related protein 4, Ig superfamily receptor LNIR, Nectin-4, Processed poliovirus receptor-related protein 4) (MaxLight 750)
Ask
View Details 
MBS6339259-02 5x 0.1 mL
PVRL4, ID (PVRL4, LNIR, PRR4, Poliovirus receptor-related protein 4, Ig superfamily receptor LNIR, Nectin-4, Processed poliovirus receptor-related protein 4) (MaxLight 750)
Ask
View Details 
MBS6335311-01 0.2 mL
PNLIPRP3, NT (PNLIPRP3, Pancreatic lipase-related protein 3) (PE)
Ask
View Details 
MBS6335311-02 5x 0.2 mL
PNLIPRP3, NT (PNLIPRP3, Pancreatic lipase-related protein 3) (PE)
Ask
View Details